Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00253-010-3006-4.

Title:
Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-α in mice | Applied Microbiology and Biotechnology
Description:
Although the use of TNF-α in the treatment of cancer is restricted due to its non-specific cytotoxicity and narrow range of applications to different cancers in clinical trials, we investigated a safe anti-cancer drug by the use of engineered bacterial capsule harboring TNF-α. The engineered bacterial capsule was designed to target cancer cells, promote a tumor-suppressive environment, and increase the efficacy of existing cancer treatments, including chemotherapy, radiotherapy, and cell therapy. The engineered bacterial capsule was constructed with Salmonella capsulizing TNF-α protein, which was produced and capsulized by Salmonella to reduce side effects of the protein. This bacterial capsule induced a tumor-suppressive environment through the activation of natural killer cells. Engineered bacterial capsule invaded tumor cells, released TNF-α, and induced apoptosis of tumor cells without apparent side effects. In a murine melanoma model, the bacterial capsule of TNF-α significantly inhibited tumor growth by 80–100% and prolonged the survival of the mice. When tested in combination with chemotherapy (cisplatin), antibiotics, and vaccine, recombinant microbial treatment increased the anti-tumor effects of existing therapies. The anti-tumor effects of the bacterial capsule of TNF-α were also observed in cervical cancer, melanoma, breast cancer, colon cancer, and renal carcinoma. These results suggest that the bacterial capsule of TNF-α is a promising strategy for TNF-α treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

google, scholar, article, cas, cancer, salmonella, tumor, bacterial, tnfα, antitumor, therapy, effects, korea, typhimurium, patients, mice, capsule, oncol, res, treatment, chemotherapy, cell, cisplatin, attenuated, phase, engineered, cells, radiotherapy, access, factor, study, gene, privacy, cookies, content, research, anticancer, activation, natural, necrosis, bermudes, toxicity, university, publish, search, biotechnology, harboring, november, yoon, park,

Topics {✒️}

tumour necrosis factor typhimurium harboring tnf-α month download article/chapter tumor necrosis factor-α yong keun park metxia-p450 gene therapy small-cell lung cancer safe anti-cancer drug tumor necrosis factor bacterial cancer therapy article applied microbiology engineered bacterial capsule tumor-targeted salmonella attenuated salmonella typhimurium related subjects human cancer therapy existing cancer treatments antitumor therapeutic effects targeted gene delivery natural killer cells released tnf-α full article pdf yang seok chae privacy choices/manage cookies bacterial capsule induced anti-tumor effects attenuated salmonella spp recombinant human tnf single-dose studies tnf-α treatment target cancer cells tumor cell lysates eukaryotic expression plasmids monocyte mediated cytotoxicity endogenous tnf-alpha article yoon advanced breast cancer escherichia coli k12 reduce side effects apparent side effects tumor-bearing mice tumor-suppressive environment low-dose leucovorin escherichia coli k-12 korea healthcare technology korea university college anti-tumor agent salmonella typhimurium antitumor factor murine tumor models

Questions {❓}

  • Pisters PW, Evans DB (2008) Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-α in mice
         description:Although the use of TNF-α in the treatment of cancer is restricted due to its non-specific cytotoxicity and narrow range of applications to different cancers in clinical trials, we investigated a safe anti-cancer drug by the use of engineered bacterial capsule harboring TNF-α. The engineered bacterial capsule was designed to target cancer cells, promote a tumor-suppressive environment, and increase the efficacy of existing cancer treatments, including chemotherapy, radiotherapy, and cell therapy. The engineered bacterial capsule was constructed with Salmonella capsulizing TNF-α protein, which was produced and capsulized by Salmonella to reduce side effects of the protein. This bacterial capsule induced a tumor-suppressive environment through the activation of natural killer cells. Engineered bacterial capsule invaded tumor cells, released TNF-α, and induced apoptosis of tumor cells without apparent side effects. In a murine melanoma model, the bacterial capsule of TNF-α significantly inhibited tumor growth by 80–100% and prolonged the survival of the mice. When tested in combination with chemotherapy (cisplatin), antibiotics, and vaccine, recombinant microbial treatment increased the anti-tumor effects of existing therapies. The anti-tumor effects of the bacterial capsule of TNF-α were also observed in cervical cancer, melanoma, breast cancer, colon cancer, and renal carcinoma. These results suggest that the bacterial capsule of TNF-α is a promising strategy for TNF-α treatment.
         datePublished:2010-11-27T00:00:00Z
         dateModified:2010-11-27T00:00:00Z
         pageStart:1807
         pageEnd:1819
         sameAs:https://doi.org/10.1007/s00253-010-3006-4
         keywords:
            Antitumor effects
            Tumor treatments
            TNF-α
             Salmonella typhimurium
            Microbiology
            Microbial Genetics and Genomics
            Biotechnology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig7_HTML.gif
         isPartOf:
            name:Applied Microbiology and Biotechnology
            issn:
               1432-0614
               0175-7598
            volumeNumber:89
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Won Suck Yoon
               affiliation:
                     name:Korea University
                     address:
                        name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
                     name:Korea University
                     address:
                        name:Office of Research, Korea University, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yang Seok Chae
               affiliation:
                     name:Korea University
                     address:
                        name:Department of Pathology, Korea University College of Medicine, Korea University, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Juyeon Hong
               affiliation:
                     name:Rice University
                     address:
                        name:Rice University, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yong Keun Park
               affiliation:
                     name:Korea University
                     address:
                        name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-α in mice
      description:Although the use of TNF-α in the treatment of cancer is restricted due to its non-specific cytotoxicity and narrow range of applications to different cancers in clinical trials, we investigated a safe anti-cancer drug by the use of engineered bacterial capsule harboring TNF-α. The engineered bacterial capsule was designed to target cancer cells, promote a tumor-suppressive environment, and increase the efficacy of existing cancer treatments, including chemotherapy, radiotherapy, and cell therapy. The engineered bacterial capsule was constructed with Salmonella capsulizing TNF-α protein, which was produced and capsulized by Salmonella to reduce side effects of the protein. This bacterial capsule induced a tumor-suppressive environment through the activation of natural killer cells. Engineered bacterial capsule invaded tumor cells, released TNF-α, and induced apoptosis of tumor cells without apparent side effects. In a murine melanoma model, the bacterial capsule of TNF-α significantly inhibited tumor growth by 80–100% and prolonged the survival of the mice. When tested in combination with chemotherapy (cisplatin), antibiotics, and vaccine, recombinant microbial treatment increased the anti-tumor effects of existing therapies. The anti-tumor effects of the bacterial capsule of TNF-α were also observed in cervical cancer, melanoma, breast cancer, colon cancer, and renal carcinoma. These results suggest that the bacterial capsule of TNF-α is a promising strategy for TNF-α treatment.
      datePublished:2010-11-27T00:00:00Z
      dateModified:2010-11-27T00:00:00Z
      pageStart:1807
      pageEnd:1819
      sameAs:https://doi.org/10.1007/s00253-010-3006-4
      keywords:
         Antitumor effects
         Tumor treatments
         TNF-α
          Salmonella typhimurium
         Microbiology
         Microbial Genetics and Genomics
         Biotechnology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00253-010-3006-4/MediaObjects/253_2010_3006_Fig7_HTML.gif
      isPartOf:
         name:Applied Microbiology and Biotechnology
         issn:
            1432-0614
            0175-7598
         volumeNumber:89
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Won Suck Yoon
            affiliation:
                  name:Korea University
                  address:
                     name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
                  name:Korea University
                  address:
                     name:Office of Research, Korea University, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yang Seok Chae
            affiliation:
                  name:Korea University
                  address:
                     name:Department of Pathology, Korea University College of Medicine, Korea University, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Juyeon Hong
            affiliation:
                  name:Rice University
                  address:
                     name:Rice University, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yong Keun Park
            affiliation:
                  name:Korea University
                  address:
                     name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Applied Microbiology and Biotechnology
      issn:
         1432-0614
         0175-7598
      volumeNumber:89
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Korea University
      address:
         name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
         type:PostalAddress
      name:Korea University
      address:
         name:Office of Research, Korea University, Seoul, Republic of Korea
         type:PostalAddress
      name:Korea University
      address:
         name:Department of Pathology, Korea University College of Medicine, Korea University, Seoul, Republic of Korea
         type:PostalAddress
      name:Rice University
      address:
         name:Rice University, Houston, USA
         type:PostalAddress
      name:Korea University
      address:
         name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Won Suck Yoon
      affiliation:
            name:Korea University
            address:
               name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
            name:Korea University
            address:
               name:Office of Research, Korea University, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Yang Seok Chae
      affiliation:
            name:Korea University
            address:
               name:Department of Pathology, Korea University College of Medicine, Korea University, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Juyeon Hong
      affiliation:
            name:Rice University
            address:
               name:Rice University, Houston, USA
               type:PostalAddress
            type:Organization
      name:Yong Keun Park
      affiliation:
            name:Korea University
            address:
               name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
      name:Office of Research, Korea University, Seoul, Republic of Korea
      name:Department of Pathology, Korea University College of Medicine, Korea University, Seoul, Republic of Korea
      name:Rice University, Houston, USA
      name:Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(106)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.75s.